News
Novo Nordisk unveils $499 cash-pay Ozempic offering amid continued compounder competition
Several months after unveiling its direct-to-consumer NovoCare Pharmacy service with the launch of a $499 cash-pay option for a monthly supply of Wegovy, Novo Nordisk is expanding the discount to include its other GLP-1 heavyweight.
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don’t go through ...
9hon MSN
Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership
TheStreet. Telemedicine company GoodRx (GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks ...
16hon MSN
Why Novo Nordisk Stock Popped Monday
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...
Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a “Hold” rating on ...
SINGAPORE] Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback